HH
BMY icon

Hilltop Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Hilltop Holdings’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Sell
25,193
-28,810
-53% -$1.68M 0.14% 168
2025
Q4 		$2.91M Buy
54,003
+12,485
+30% +$601K 0.17% 138
2025
Q3 		$1.87M Sell
41,518
-3,555
-8% -$166K 0.1% 229
2025
Q2 		$2.09M Sell
45,073
-2,776
-6% -$136K 0.13% 175
2025
Q1 		$2.92M Buy
47,849
+4,328
+10% +$252K 0.18% 134
2024
Q4 		$2.46M Buy
43,521
+6,105
+16% +$341K 0.16% 153
2024
Q3 		$1.94M Buy
37,416
+5,987
+19% +$281K 0.12% 185
2024
Q2 		$1.31M Buy
31,429
+7,794
+33% +$349K 0.15% 174
2024
Q1 		$1.28M Buy
23,635
+889
+4% +$45.3K 0.13% 186
2023
Q4 		$1.17M Sell
22,746
-10,037
-31% -$527K 0.13% 194
2023
Q3 		$1.9M Buy
32,783
+1,975
+6% +$121K 0.22% 124
2023
Q2 		$1.97M Buy
30,808
+7,618
+33% +$511K 0.24% 108
2023
Q1 		$1.61M Buy
23,190
+913
+4% +$64.4K 0.21% 104
2022
Q4 		$1.6M Sell
22,277
-475
-2% -$35.8K 0.21% 112
2022
Q3 		$1.62M Sell
22,752
-14,027
-38% -$1.02M 0.22% 101
2022
Q2 		$2.83M Buy
36,779
+1,689
+5% +$129K 0.37% 57
2022
Q1 		$2.56M Sell
35,090
-9,928
-22% -$667K 0.29% 77
2021
Q4 		$2.81M Buy
45,018
+588
+1% +$34.5K 0.29% 77
2021
Q3 		$2.63M Buy
44,430
+2,537
+6% +$167K 0.29% 82
2021
Q2 		$2.8M Buy
41,893
+9,293
+29% +$606K 0.32% 70
2021
Q1 		$2.06M Buy
32,600
+12,782
+64% +$795K 0.27% 89
2020
Q4 		$1.23M Sell
19,818
-1,861
-9% -$114K 0.17% 131
2020
Q3 		$1.31M Buy
21,679
+5,644
+35% +$340K 0.22% 103
2020
Q2 		$943K Sell
16,035
-422
-3% -$25.2K 0.17% 132
2020
Q1 		$918K Buy
16,457
+1,753
+12% +$107K 0.22% 104
2019
Q4 		$944K Buy
14,704
+1,944
+15% +$111K 0.18% 139
2019
Q3 		$647K Buy
12,760
+3,722
+41% +$175K 0.12% 175
2019
Q2 		$410K Sell
9,038
-7,174
-44% -$334K 0.09% 227
2019
Q1 		$774K Buy
16,212
+8,671
+115% +$432K 0.16% 137
2018
Q4 		$392K Sell
7,541
-1,313
-15% -$70.5K 0.1% 205
2018
Q3 		$550K Sell
8,854
-1,223
-12% -$72.6K 0.12% 217
2018
Q2 		$557K Sell
10,077
-1,597
-14% -$86.3K 0.12% 197
2018
Q1 		$739K Sell
11,674
-16,209
-58% -$1.04M 0.13% 176
2017
Q4 		$1.71M Buy
27,883
+3,329
+14% +$208K 0.39% 72
2017
Q3 		$1.56M Sell
24,554
-3,734
-13% -$218K 0.47% 67
2017
Q2 		$1.58M Buy
28,288
+1,062
+4% +$57.8K 0.46% 67
2017
Q1 		$1.48M Buy
27,226
+709
+3% +$38.9K 0.45% 70
2016
Q4 		$1.55M Sell
26,517
-3,704
-12% -$202K 0.49% 58
2016
Q3 		$1.63M Sell
30,221
-384
-1% -$24.7K 0.51% 58
2016
Q2 		$2.25M Buy
30,605
+1,487
+5% +$105K 0.72% 35
2016
Q1 		$1.86M Sell
29,118
-740
-2% -$46.7K 0.58% 45
2015
Q4 		$2.06M Buy
29,858
+955
+3% +$63.1K 0.6% 41
2015
Q3 		$1.71M Buy
28,903
+2,462
+9% +$156K 0.5% 61
2015
Q2 		$1.76M Sell
26,441
-56
-0.2% -$3.69K 0.48% 71
2015
Q1 		$1.71M Buy
26,497
+21,189
+399% +$1.33M 0.44% 74
2014
Q4 		$313K Sell
5,308
-3,178
-37% -$179K 0.11% 154
2014
Q3 		$434K Buy
8,486
+659
+8% +$32.9K 0.2% 126
2014
Q2 		$379K Buy
7,827
+503
+7% +$24.8K 0.18% 141
2014
Q1 		$380K Buy
+7,324
New +$390K 0.19% 131

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hilltop Holdings's BMY Position: Q1 2026 in Review

Hilltop Holdings reduced its Bristol-Myers Squibb (BMY) stake by 53% in Q1 2026, selling an estimated $1.68M and leaving 25,193 shares worth $1.53M. The position accounts for 0.14% of the portfolio, ranked #168.

Hilltop Holdings first reported a position in BMY in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.92M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hilltop Holdings held 25,193 shares of Bristol-Myers Squibb worth $1.53M as of Q1 2026.
  • Hilltop Holdings sold 28,810 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.68M.
  • Bristol-Myers Squibb made up 0.14% of Hilltop Holdings's portfolio in Q1 2026, its #168 holding.
  • Hilltop Holdings first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 49 quarters since.
  • Hilltop Holdings's Bristol-Myers Squibb position peaked at $2.92M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.